skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines atezolizumabQuestion & answer

atezolizumab · Medicine question

Can atezolizumab cause pneumonitis?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Yes, atezolizumab can cause immune-mediated pneumonitis, including fatal cases.

Sources for this answer

Tecentriq 840 mg and 1,200 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 44Document updated 8 October 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

atezolizumab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

More questions about atezolizumab

Which liver blood tests should be monitored before and during atezolizumab treatment?Are clinical data available on the effects of atezolizumab on fertility?For which adults with hepatocellular carcinoma is atezolizumab (Tecentriq) indicated in combination with bevacizumab?Have the safety and efficacy of atezolizumab (Tecentriq) been established in children under 18?How does atezolizumab act on PD-L1 to reactivate the antitumour immune response?How long does the first intravenous infusion of atezolizumab (Tecentriq) take?

Read the atezolizumab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX